Pacific Biosciences of California, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value
Pacific Biosciences of California, Inc. (PACB) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value of $2.90 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 · last filed 2020-02-28
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2019 was $2.90M, a 25.64% decline from fiscal 2018.
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2018 was $3.90M, a 39.06% decline from fiscal 2017.
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2017 was $6.40M, a 69.08% decline from fiscal 2016.
- Pacific Biosciences of California, Inc. share-based compensation arrangement by share-based payment award, options, vested in period, fair value for fiscal 2016 was $20.70M, a 183.56% increase from fiscal 2015.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value 12 month |
|---|---|
| 2019-12-31 | $2.90M 10-K · filed 2020-02-28 |
| 2018-12-31 | $3.90M 10-K · filed 2020-02-28 |
| 2017-12-31 | $6.40M 10-K · filed 2020-02-28 |
| 2016-12-31 | $20.70M 10-K · filed 2019-02-26 |
| 2015-12-31 | $7.30M 10-K · filed 2018-02-26 |
| 2014-12-31 | $6.00M 10-K · filed 2017-03-06 |
| 2013-12-31 | $6.50M 10-K · filed 2016-03-11 |
| 2012-12-31 | $2.30M 10-K · filed 2015-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |